Emerging infectious diseases caused by viruses have assumed great public health significance in the recent past. During the last three decades, almost twenty new viral pathogens have been detected. Some of these have already caused substantial mortality, morbidity and economic loss across the globe. The recent COVID-19 pandemic caused due to the spread of coronavirus unequivocally demonstrated the rapidity with which new viruses can travel across the world and inflict misery—is the most significant public health challenge in the current millennium so far.
As viral infections diagnosis demands novel, cheaper and rapid technologies to overcome present constraints, the current gold standard for diagnosis of viral infections is based on pathogen-targeted nucleic acid identification. Thus, it cannot discern infectious stages from latent ones, and it demands time-consuming adjustments when mutations occur, or new emerging viruses are to be included in the diagnostic protocols. Now, developing viral vaccines and antiviral drugs is exceptionally challenging. Due to complex nature, virologists first need to solve the virus structure and understand its life cycle. This knowledge is what enables the foundation of effective vaccines and the search for drugs that can inhibit or block a crucial step in the virus’ life cycle. Virology Tech companies offer novel technology capable of identifying viral particles and asses their infective potential. These companies provide personalized treatment to the patients, reducing the use of not effective antibiotics, increasing safety in blood transfusions, allowing a quick and trustworthy response to emergencies, reducing the spread of viral infections, reducing costs per analysis and screening of a wide range of pathogens.
Through this edition of Pharma Tech Outlook, our editorial team wishes to highlight the top players within the virology tech industry, aiming to showcase eventful avenues in the arena through a peer to peer knowledge delivery approach.
Pharma Tech Outlook is proud to present its list of “Top 10 Virology Tech Companies in Europe - 2020.”
